Interactions of β-amyloids with the blood-brain barrier

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 190-199

  Banks, William A ^a,b   Kastin, Abba J ^a,b   Maness, Lawrence M ^a,b   Banks, Marian F ^a,c   Shayo, Marcos ^a,d   McLay, Robert N ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LSUHSC School of Nursing   (United States)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; CALCIUM ION; CELL ENZYME; CLUSTERIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN FUNCTION; BRAIN TISSUE; CELL MEMBRANE; CEREBROSPINAL FLUID; CONFERENCE PAPER; HUMAN; ISOTOPE LABELING; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN TRANSPORT;

ANIMALIA;

EID: 0030714186     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48470.x     Document Type: Conference Paper

References (56)

1. JOACHIM, C. L., H. MORI & D. J. SELKOE. 1989. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341: 226-230.
2. DAVSON, H. & M. B. SEGAL. 1996. Physiology of the CSF and Blood-Brain Barriers. CRC Press. Boca Raton, FL.
3. BRADBURY, M. 1979. The Concept of a Blood-Brain Barrier. John Wiley. New York.
4. NILSSON, C., M. LINDVALL-AXELSSON & C. OWMAN. 1992. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res. Rev. 17: 109-138.
5. JOHANSON, C. E. 1988. The choroid plexus-arachnoid membrane-cerebrospinal fluid system. In Neuromethods: The Neuronal Microenvironment. A. A. Boulton, G. B. Baker & W. Walz, Eds.: 33-104. Humana Press. Clifton, NJ.
6. RAPOPORT, S. I. 1976. Blood Brain Barrier in Physiology and Medicine. Raven Press. New York.
7. BROADWELL, R. D. & M. V. SOFRONIEW. 1993. Serum proteins by-pass the blood-brain barrier for extracellular entry to the central nervous system. Exp. Neurol. 120: 245-263.
8. BALIN, B. J., R. D. BROADWELL, M. SALCMAN & M. EL-KALLINY. 1986. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J. Comp. Neurol. 251: 260-280.
9. BANKS, W. A. & R. D. BROADWELL. 1994. Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin and albumin: Pharmacokinetic and morphological assessments. J. Neurochem. 62: 2404-2419.
10. OLDENDORF, W. H. 1974. Lipid solubility and drug penetration of the blood-brain barrier. Proc. Soc. Exp. Biol. Med. 147: 813-816.
11. BANKS, W. A. & A. J. KASTIN. 1993. Peptide binding in blood and passage across the blood-brain barrier. In Proceedings of the International Symposium on Blood Binding and Drug Transfer. J. P. Tillement, H. Eckert, E. Albengres, J. Barre, P. Baumann, F. Belpare & M. Lemaire, Eds.: 223-242. Fort and Clair. Paris.
12. OLDENDORF, W. H. 1971. Brain uptake of radio-labelled amino acids, amines and hexoses after arterial injection. Am. J. Physiol. 221: 1629-1639.
13. BANKS, W. A. & A. J. KASTIN. 1995. Peptide transport system-1. In New Concepts of a Blood-Brain Barrier. J. Greenwood, D. J. Begley & M. B. Segal, Eds.: 111-117. Plenum Press. New York.
14. DE VIVO, D. C., R. R. TRIFILETTI, R. I. JACOBSON, G. M. RONEN, R. A. BEHMAND & S. I. HARIK. 1991. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N. Engl. J. Med. 325: 703-709.
15. BANKS, W. A. & A. J. KASTIN. 1990. Editorial review: Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259: E1-E10.
16. WOODS, S. C. & D. PORTE, JR. 1983. The role of insulin as a satiety factor in the central nervous system. In Advances in Metabolic Disorders, CNS Regulation of Carbohydrate Metabolism, Vol. 10. A. J. Szabo, Ed.: 457-482. Academic Press. New York.
17. BAURA, G. D., D. M. FOSTER, D. PORTE, JR., S. E. KAHN, R. N. BERGMAN, C. COBELLI & M. W. SCHWARTZ. 1993. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92: 1824-1830.
18. SCHWARTZ, M. W., E. PESKIND, M. RASKIND, E. J. BOYKO & D. PORTE, JR. 1996. Cerebrospinal fluid leptin levels: Relationship to plasma levels and adiposity in humans. Nature Medicine 2: 589-593.
19. BANKS, W. A., A. J. KASTIN, W. HUANG, J. B. JASPAN & L. M. MANESS. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-311.
20. BANKS, W. A. & A. J. KASTIN. 1989. Inhibition of the brain to blood transport system for enkephalins and Tyr-MIF-1 in mice addicted or genetically predisposed to drinking ethanol. Alcohol 6: 53-57.
21. LUHESHI, G. N., J. GAY & N. J. ROTHWELL. 1994. Circulating IL-6 is transported into the brain via a saturable transport mechanism in the rat. Br. J. Pharmacol. 112: 637P.
22. ROMERO, L.I., K. ILDIKO, R. M. LECHAN & S. REICHLIN. 1996. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1β in rats. Am. J. Physiol. 270: R518-R524.
23. PAN, W., W. A. BANKS, M. K. KENNEDY, E. G. GUTIERREZ & A. J. KASTIN. 1996. Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am. J. Physiol. 34: E636-E642.
24. LOSSINSKY, A. S., R. PLUTA, M. J. SONG, V. BADMAJEW, R. C. MORETZ & H. M. WISNIEW-SKI. 1991. Mechanisms of inflammatory cell attachment in chronic relapsing experimental allergic encephalomyelitis: a scanning and high-voltage electron microscopic study of the injured mouse blood-brain barrier. Microvasc. Res. 41: 299-310.
25. PARDRIDGE, W. M., J. L. BUCIAK, Y.-S. KANG & R. J. BOADO. 1993. Protamine-mediated transport of albumin into brain and other organs of the rat: Binding and endocytosis of protamine-albumin complex by microvascular endothelium. J. Clin. Invest. 92: 2224-2229.
26. BETZ, A. L. & G. W. GOLDSTEIN. 1978. Polarity of the blood-brain barrier: Neutral amino acid transport into isolated brain capillaries. Science 202: 225-227.
27. CORDON-CARDO, C., J. P. O'BRIEN, D. CASALS, L. RITTMAN-GRAUER, J. L. BIEDLER, M. R. MELAMED & J. R. BERTINO. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86: 695-698.
28. TSUJI, A., T. TERASAKI, Y. TAKABATAKE, Y. TENDA, I. TAMAI, T. YAMASHIMA, S. MORITANI, T. TSURUO & J. YAMASHITA. 1992. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51: 1427-1437.
29. BEGLEY, D. J. 1992. The interaction of some centrally active drugs with the blood-brain barrier and circumventricular organs. Prog. Brain Res. 91: 163-169.
30. BEGLEY, D. J. 1994. Strategies for delivery of peptide drugs to the central nervous system: Exploiting molecular structure. J. Control. Release 29: 293-306.
31. 1-28 (Alzheimer's disease protein). Brain Res. Bull. 27: 819-823.
32. BANKS, W. A., A. J. KASTIN & R. D. BROADWELL. 1995. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2: 241-248.
33. ZLOKOVIC, B. V., J. GHISO, J. B. MACKIC, J. G. MCCOMB, M. H. WEISS & B. FRANGIONE. 1993. Blood-brain barrier transport of circulating Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 197: 1034-1040.
34. MANESS, L. M., W. A. BANKS, M. B. PODLISNY, D. J. SELKOE & A. J. KASTIN. 1994. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci. 21: 1643-1650.
35. TRIGUERO, D., J. BUCIAK & W. M. PARDRIDGE. 1990. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54: 1882-1888.
36. ZLOKOVIC, B. V., D. J. BEGLEY, B. M. DJURICIC & D. M. MITROVIC. 1986. Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: Method and application to N-methyl-α-aminoisobutyric acid. J. Neurochem. 46: 1444-1451.
37. ZLOKOVIC, B. V., C. L. MARTEL, J. B. MACKIC, E. MATSUBARA, T. WISNIEWSKI, J. G. MCCOMB, B. FRANGIONE & J. GHISO. 1994. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 205: 1431-1437.
38. ZLOKOVIC, B. V., C. L. MARTEL, E. MATSUBARA, J. G. MCCOMB, G. ZHENG, R. T. MCCLUSKEY, B. FRANGIONE & J. GHISO. 1996. Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA 93: 4229-4234.
39. MURPHY, B. F., L. KIRSZBAUM, I. D. WALKER & A. J. F. D'APICE. 1988. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J. Clin. Invest. 81: 1858-1864.
40. SHAYO, M., R. N. MCLAY, A. J. KASTIN & W. A. BANKS. 1997. The putative blood-brain barrier transporter for the β-amyloid binding protein apolipoprotein J is saturated at physiological concentrations. Life Sci. 60: PL115-PL118.
41. KUROCHKIN, I. V. & S. GOTO. 1994. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345: 33-37.
42. 2+-dependent 68-kilodalton protease in familial Alzheimer's disease cells cleaves the N-terminus of β-amyloid. Biochemistry 33: 3941-3948.
43. SHORTLE, W. C. & K. T. SMITH. 1988. Aluminum-induced calcium deficiency syndrome in declining red spruce. Science 240: 1017-1018.
44. KINRAIDE, T. B. & D. R. PARKER. 1987. Cation amelioration of aluminum toxicity in wheat. Plant Physiol. 83: 546-551.
45. MARTYN, C. N., C. OSMOND, J. A. EDWARDSON, D. J. P. BARKER, E. C. HARRIS & R. F. LACEY. 1989. Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet i: 59-62.
46. CRAPPER, D. R., S. QUITTKAT, S. S. KRISHNAN, A. J. DALTON & U. DE BONI. 1980. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathol. (Berl.) 50: 19-24.
47. ALFREY, A. C., J. M. MISHELL & J. BURKS. 1972. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans. Am. Soc. Artif. Inter. Organs 18: 257-261.
48. BOWDLER, N. C., D. S. BEASLEY, E. C. FRITZE, A. M. GOULETTE, J. D. HATTON, J. HESSION, D. L. OSTMAN, D. J. RUGG & C. J. SCHMITTDIEL. 1979. Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol. Biochem. Behav. 10: 505-512.
49. BUGIANI, O. & B. GHETTI. 1982. Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder. Neurobiol. Aging 3: 209-222.
50. ARISPE, N., E. ROJAS & H. B. POLLARD. 1993. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90: 567-571.
51. EXLEY, C., N. C. PRICE, S. M. KELLY & J. D. BIRCHALL. 1993. An interaction of β-amyloid with aluminium in vitro. FEBS Lett. 324: 293-295.
52. MANTYH, P. W., J. R. GHILARDI, S. ROGERS, E. DEMASTER, C. J. ALLEN, E. R. STIMSON & J. E. MAGGIO. 1993. Aluminum, iron, and zinc ions promote aggregation of physiological concentration of β-amyloid peptide. J. Neurochem. 61: 1171-1174.
53. 1-40 by murine and human intracellular enzymes. Neurotoxicol. Teratol. 18: 671-677.
54. ENGSTROM, I., G. RONQUIST, L. PETTERSSON & A. WALDENSTROM. 1995. Alzheimer amyloid β-peptides exhibit ionophore-like properties in human erythrocytes. Eur. J. Clin. Invest. 25: 471-476.
55. BANKS, W. A., A. J. KASTIN, L. M. MANESS, W. HUANG & J. B. JASPAN. 1995. Permeability of the blood-brain barrier to amylin. Life Sci. 57: 1993-2001.
56. BANKS, W. A., A. J. KASTIN, M. B. FASOLD, C. M. BARRERA & G. AUGEREAU. 1988. Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain Res. Bull. 21: 881-885.